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Activation of Dihaloalkanes by Glutathione
Conjugation and Formation of DNA
Adducts
by F. Peter Guengerich,* Lisa A. Peterson,* Joan L.
Cmarik,* Nobuyuki Koga,* and Philip B. Inskeep*
Ethylene dibromide (1,2-dibromoethane, EDB) can be activated to electrophilic species by either oxi-
dative metabolism or conjugation with glutathione. Although conjugation is generally a route of detox-
ication, in this case it leads to genetic damage. The major DNA adduct has been identified as S-[2-(N7-
guanyl)ethyl]glutathione, which is believed to arise via half-mustard and episulfonium ion intermediates.
The adduct has a half-life of about 70 to 100 hr and does not appear to migrate to other DNA sites.
Glutathione-dependent DNA damage by EDB was also demonstrated in human hepatocyte preparations.
The possible relevance of this DNA adduct to genetic damage is discussed.
Introduction
Many halogenated hydrocarbons are of concern
because ofindustrial and environmental exposure. With
the apparent exception of halogenated dioxins, biphen-
yls, and related compounds, most of these chemicals
require metabolic bioactivation to exert their biological
effects, at least genetic damage. Several enzymatic
pathways can be involved in such bioactivation, includ-
ing mixed-function oxidation and reduction by cyto-
chrome P-450 (P-450) enzymes. In recent years another
mechanism for activation has been identified, that of
conjugation with the physiological nucleophile glutathi-
one (GSH). This reaction appears to be largely restrict-
ed to 1,2-dihaloalkanes. Several of these are of partic-
ular concern. 1,2-Dibromoethane (ethylene dibromide,
EDB) has beenused as apesticide andgasolineadditive;
it produces tumors at a number of sites in rodents (1-
3) and is acutely toxic to rodents (1) and man (4). 1,2-
Dichloroethane (ethylene dichloride, EDC) is used in
the production of vinyl chloride; it can produce tumors
in mice when administered via specific routes (5). Evi-
dence forthe existence ofthis reaction in the production
ofDNA adducts from vic-dihaloalkanes is reviewed and
the relevance of these adducts is discussed.
Chemistry of Formation of DNA
Adducts
The work in this laboratory was based upon the
reports ofRannug et al. (6) that bacterial mutagenesis
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inducedbyEDC wasdependentupontheactionofGSH-
dependent cytosolic enzymes and not microsomal
mixed-function oxidases. We repeated these experi-
ments and also found that the covalent binding ofradio-
activity from [1,2-14C]-EDC followed a similar pattern
(7). The pathway postulated by Rannug (8) would be
expected to yield covalent attachment ofGSH to DNA,
and subsequentexperimentswithpurifiedGSH S-trans-
ferases and isolated rat hepatocytes showed thatradiol-
abelsfromboth EDB andGSHbecamecovalentlybound
to DNA in equimolar ratios (9).
The DNA adduct formed from EDB in vitro was
cleaved enzymatically and partially purified. Reduction
of the resulting sample with a modified Raney nickel
procedure yielded N -ethylguanine, consistent with the
view that the original adduct was S-[2-(N7-guanyl)
ethyl]-GSH (9). Subsequently, the adduct could be re-
leased from DNA by neutral thermal hydrolysis and
isolatedusingacombinationofreversedphaseandanion
exchange high performance liquid chromatography
(HPLC). The structure S-42-(N7-guanyl)ethyl]GSH
(Fig.1) was unambiguously established by fast atom
bombardment mass spectrometry and two-dimensional
homonuclear NMR correlated spectroscopy (10). No
evidence foropeningofthe imidazole ringwas observed
in these experiments. In the case of [1,2-14C]-EDB ad-
ducts formed in vitro or in vivo (rat liver or kidney),
more than 97% ofthe radioactivity bound to DNA could
be released by neutral thermal hydrolysis and, ofthis,
>90% migrated as S-[2-(N7-guanyl)ethyl]GSH upon
HPLC.
Several mechanisms are possible for the formation of
the adduct; we prefer a pathway involving an episul-GUENGERICH ET AL.
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FIGURE 1. Structure of S-[2-(N7-guanyl)ethyl]GSH.
fonium (thiiranium) ion intermediate (Fig. 2). Studies
on the alkylation of model nucleophiles by S-(2-chloro-
ethyl)cysteine derivatives indicate that the thioether
moiety is essential for alkylation. A protonated amine
retards alkylation; alkylationisfacilitated byraisingthe
pH to deprotonate the amine, acetylation ofthe amine,
orthe addition ofamethylene group (homocysteine ana-
log) to introduce an inductive effect and move the pos-
itively charged amine away from the incipient episul-
fonium ion. These results are consistent with a mech-
anism which involves an episulfonium ion; in addition,
these model studies argue that if the -y-glutamyl bond
were cleaved to generate a free amine at neutral pH,
the alkylation of DNA should be retarded and not
enhanced.
The above model studies argue against a role for ry-
glutamyl transpeptidase in modulating the alkylation of
DNA. In other studies we found that inhibition of -y-
glutamyl transpeptidase activity in vitro or in vivo did
not affect the level of DNA adducts formed in liver or




One question concerning S-[2-(N7-guanyl)ethyl]GSH
adducts in DNA is whether they can break down to
GSH -XH20
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FIGURE 2. Reactions related to metabolism of EDB. '
* GS %"OH
regenerate the episulfonium ion, i.e., whether guanine
can act as a leaving group. This question is relevant in
consideringthe potential ofEDB adducts inmeat, milk,
and other foods to alkylate host DNA after ingestion.
We incubated S-[2-(N7-guanyl)(1,2-14C)ethyl]GSH with
calf thymus DNA for 3 hr at neutral pH; under these
conditions no labeling of the DNA could be detected
(11). Thus, such a transalkylation reaction does not
appear to be a matter of concern.
We established a half-life of S-[2-(N7-guanyl)ethyl]-
GSH in calfthymus DNA ofabout 150 hr at neutral pH
and 37°C. In rat liver, kidney, lung, and stomach the
in vivo half-life was 70 to 100 hr (11). In the case of
liver, comparison of data based on total DNA-bound
radioactivity and on HPLC separation ofS-[2-(N7-guan-
yl)ethyl]GSH as a function oftime yielded similar half-
life values (11).
Consideration of Other Dihalides
EDC appears to be activated by the same mechanism
as EDB (6,7). We also detected S-[2-(N7-guanyl)ethyl]-
GSH in the liver and kidney DNA of rats treated with
EDC, although the levels of binding were much lower
and, in the case of kidney, other adducts appeared to
be present as well (11). The mixed halide 1-bromo-2-
chloroethane is activated via the same mechanism, and
the expected halide order is observed (9).
Insertion of more methylene groups into these a,w-
substituted haloalkanes abolished the reaction with
DNA (although these are actually better substrates for
GSH S-transferase). In vitro evidence for some DNA
adduct formation via the GSH-conjugation pathway
could be obtained for 1,2-dibromo-3-chloropropane and
tris(2,3-dibromopropyl)phosphate, although the contri-
bution of oxidative pathways seems to be more impor-
tant (12). The question of dihalomethanes is quite rel-
evant: The GSH-dependent formation of HCHO from
these compounds has been reported (13), but only very
limited data implicating GSH/GSH S-transferase-
mediated bacterial mutagenesis are available (14-16).
Experiments Involving Humans
Hepatocytes wereisolatedfromfiveindividualhuman
liver samples using the technique of collagenase incu-
GS-'%SG bation ofliverslices. ThelevelofDNAadductformation
in the human samples was about 40% of that in rat
hepatocytes prepared in the same manner (0.16 vs. 0.45
nmole adducts formed/mg DNA/2 hr).
In other experiments (with M. J. Meredith), human
hepatocytes were isolated and allowed to form mono-
layers. EDB dose-dependent incorporation of 3H-thy-
midine into DNA (unscheduled DNA synthesis) could
~SG bedemonstrated overtherangeofl0-7to 0-3M EDB.
The unscheduled DNA synthesis could be nearly abol- >_ ished if the cells were treated with 0.5 mM diethyl-
maleate (prior to EDB incubation) to deplete GSH.
However, treatment with diethylmaleate after EDB
See text. incubation had only a small effect on the EDB dose-
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dependentunscheduled DNAsynthesis, consistent with
the view thatboth EDB and GSH are required for DNA
alkylation. These studies also suggest that some enzy-
matic DNA repair can occur.
Recently, Letz et al. (4) reported the death of two
workers due to EDB intoxication. We have isolated
DNA samples from one of these individuals and are
presently attempting to estimate the levels ofS-[2-(N7-
guanyl)ethyl]GSH using a postlabeling method.
Relevance to Risk Assessment and
Future Considerations
This article has reviewed evidence that the major
DNA adduct formed from EDB and EDC is S-[2-(N7-
guanyl)ethyl]GSH, which is formed viareaction ofS-(2-
haloethyl)GSH and episulfoniumintermediates withthe
N7 position ofguanine to yield a bulky adduct (Fig. 3).
The physiological half-life of the adduct is 70 to 100 hr
andtransalkylationdoesnotapparentlyoccur. Thebasic
reaction appears to occur in human samples and with
some related vic-dihaloalkanes.
The question arises as to whether or not this particu-
lar DNA adduct is responsible for the biological prop-
ertiesofvic-dihaloalkanes, particularlytumorinitiation.
Several lines of evidence support the view that GSH-
dependent reactions are related to genetic damage
(Table 1). However, a problem exists in that guanyl N7
adducts are not in the DNA base-pairing region, and
among the N7 purine lesions, only aflatoxin adducts are
thought to be associated with mutation. However, afla-
toxin B1 apparently forms only N7 guanyl adducts and
theresultingimidazole ring-opened derivatives as DNA
adducts, but these are highly effective in causing muta-
tions; further, aflatoxin B1 also gives rise to a mutation
at the guanyl residue in codon 12 ofthe c-rasK gene to
yield an active oncogene capable of transforming NIH
3T3 cellsinculture (21). Nevertheless, wecannotatthis
time discount the possibility that other DNA adducts
are formed in small amounts and are responsible forthe
biological effects of EDB and other vic-dihaloalkanes.
Further experiments are in progress in this laboratory
to test the hypothesis that S-[2-(N7-guanyl)ethyl]GSH
is the major mutagenic lesion formed.
The point should be made that GSH conjugation is
generally a detoxicating process, but here the reaction
can place the organism at risk. Attempts to intervene
in metabolic processes and increase GSH or GSH S-
transferase levels could render the host at greater risk.
FIGURE 3. Space-filling models of (left) guanine and (right) S-[2-(N7-guanyl)ethyl]GSH.
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Table 1. Evidence for the involvement of GSH conjugation in
genetic damage of vic-dihaloalkanes.
Reference
Bacterial mutagenicity depends upon (8)
cytosolic enzymes and GSH
In vitro DNA binding depends upon (7)
cytosolic enzymes and GSH
DNA strand breaks enhanced by (17)
deuterium substitution




Major DNA adduct contains GSH (9,10)
In vitro unscheduled DNA synthesis This report, (20)
is GSH-dependent
Further, this case points out the inherent dangers in
assuming that all electrophilic and reactive chemical
species are identical. Oxidation of EDB and EDC pro-
ducesthe2-haloacetaldehydes, whichreactrapidlywith
thiols but not with DNA (22). Further, the level of 2-
haloacetaldehydes produced in vivo appears to be con-
siderably higherthan S-(2-haloethyl)GSH (23). An addi-
tional complication in all ofthese considerations is that
GSH still has at least two detoxicating roles (Fig. 2),
and estimating rate constants for all of the individual
reactions and modeling the overall scheme is difficult.
Several lines ofevidence indicate thatthese reactions
probablydo occurinhumans. However, thedatatodate
are limited and meaningful rodent/human extrapola-
tions are difficult. The possibility exists that depuri-
nation of S-42-(N7-guanyl)ethyl]GSH may be followed
by processing to yield a urinary mercapturic acid to
expedite dosimetry.
Supported in part by USPHS grants ES 01590, ES 07028, and ES
00267. F.P.G. is a Burroughs Wellcome Scholar in Toxicology (1983-
1988). L.A.P. is the recipient ofUSPHS Postdoctoral Fellowship ES
05365 and P.B.I. wastherecipient ofUSPHS PostdoctoralFellowship
ES 05297.
REFERENCES
1. Wong, L. C. K., Winston, J. M., Hong, C. B., and Plotnick, H.
Carcinogenicity andtoxicityof1,2-dibromoethane inthe rat. Tox-
icol. Appl. Pharmacol. 63: 155-165 (1982).
2. National Toxicology Program. Carcinogenesis Bioassay of 1,2-
Dibromoethane inF344RatsandB6C3F, Mice (InhalationStudy).
Technical Report Series No. 210, 1982.
3. Weisburger, E. K. Carcinogenicity studies onhalogenated hydro-
carbons. Environ. Health Perspect. 21: 7-16 (1977).
4. Letz, G. A., Pond, S. M., Osterloh, J. D., Wade, R. L., and
Becker, C. E. Two fatalities after acute occupational exposure to
ethylene dibromide. J. Am. Med. Assoc. 252: 2428-2431 (1984).
5. National Cancer Institute. Technical Background Information-
Report on Carcinogenesis Bioassay of1,2-Dibromoethane (EDB).
U.S. Department of Health, Education and Welfare, National
Cancer Institute, Bethesda, MD 20014, September 26, 1978.
6. Rannug, U., Sundvall, A., and Ramel, C. The mutagenic effect
of 1,2-dichloroethane on Salmonella typhimurium. I. Activation
through conjugation with glutathione invitro. Chem.-Biol. Inter-
act. 20: 1-16 (1978).
7. Guengerich, F. P., Crawford, W. M., Jr., Domoradzki, J. Y.,
Macdonald, T. L., and Watanabe, P. G. In vitro activation of1,2-
dichloroethane by microsomal and cytosolic enzymes. Toxicol.
Apple. Pharmacol. 55: 303-317 (1980).
8. Rannug, U. Genotoxic effects of 1,2-dibromoethane and 1,2-dich-
loroethane. Mutat. Res. 76: 269-295 (1980).
9. Ozawa, N., and Guengerich, F. P. Evidence for formation of an
S-[2-(N7-guanyl)ethyl]glutathione adductinglutathione-mediated
binding ofthe carcinogen 1,2-dibromoethane to DNA. Proc. Natl.
Acad. Sci. (U.S.) 80: 5266-5270 (1983).
10. Koga, N., Inskeep, P. B., Harris, T. M., and Guengerich, F. P.
S-[2-(N7-Guanyl)ethyl]glutathione, the major DNA adduct
formed from 1,2-dibromoethane. Biochemistry 25: 2192-2198
(1986).
11. Inskeep, P. B., Koga, N., Cmarik, J. L., and Guengerich, F. P.
Covalent binding of1,2-dihaloalkanes to DNA and stability ofthe
major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione. Cancer
Res. 46: 2839-2844 (1986).
12. Inskeep, P. B., andGuengerich, F. P. Glutathione-mediated bind-
ing of dibromoalkanes to DNA: Specificity of rat glutathione S-
transferases anddibromoalkane structure. Carcinogenesis 5:805-
808 (1984).
13. Ahmed, A. E., and Anders, M. W. Metabolism ofdihalomethanes
to formaldehyde and inorganic halide. I. In vitro studies. Drug
Metab. Disp. 4: 357-361 (1976).
14. Jongen, W. M. F., Alink, G. M., and Koeman, J. H. Mutagenic
effect of dichloromethane on Salmonella typhimurium. Mutat.
Res. 56: 245-248 (1978).
15. van Bladeren, P. J., Breimer, D. D., Rotteveel-Smijs, G. M. T.,
and Mohn, G. R. Mutagenic activation ofdibromoethane and diio-
domethane by mammalian microsomes and glutathione S-trans-
ferases. Mutat. Res. 74: 341-346 (1980).
16. Green, T. The metabolic activation ofdichloromethane and chlo-
rofluoromethane in a bacterial mutation assay using Salmonella
typhimurium. Mutat. Res. 118: 277-288 (1983).
17. White, R. D., Gandolfi, A. J., Bowden, G. T., and Sipes, I. G.
Deuterium isotope effect on the metabolism and toxicity of 1,2-
dibromoethane. Toxicol. Appl. Pharmacol. 69: 170-178 (1983).
18. Storer, R. D., and Conolly, R. B. An investigation ofthe role of
microsomal oxidative metabolism in the in vivo genotoxicity of
1,2-dichloroethane. Toxicol. Appl. Pharmacol. 77: 36-46 (1985).
19. van Bladeren, P. J., Breimer, D. D., Rotteveel-Smijs, G. M. T.,
DeJong, R. A., Buijs, W., van der Gen, A., and Mohn, G. R. The
roleofglutathione conjugation inthemutagenicityof1,2-dibromo-
ethane. Biochem. Pharmacol. 29: 2975-2982 (1980).
20. Working, P. K., Smith-Oliver, T., White, R. D., and Butter-
worth, B. E. Induction of DNA repair in rat spermatocytes and
hepatocytes by 1,2-dibromoethane: The role of glutathione con-
jugation. Carcinogenesis 7: 467-472 (1986).
21. McMahon, G., Hanson, L., Lee, J-J., and Wogan, G. N. Identi-
fication of an activated c-Ki-ras oncogene in rat liver tumors
induced by aflatoxin B1. Proc. Natl. Acad. Sci. (U.S.) 83: 9418-
9422 (1986).
22. Guengerich, F. P., Mason, P. S., Stott, W. T., Fox, T. R., and
Watanabe, P. G. Roles of 2-haloethylene oxides and 2-haloace-
taldehydes derived from vinyl bromide and vinyl chloride in irre-
versible binding to protein and DNA. Cancer Res. 41: 4391-4398
(1981).
23. van Bladeren, P. J., Breimer, D. D., van Huijgevoort, J. A. T.
C. M., Vermeulen, N. P. E., and van der Gen, A. The metabolic
formation of N-acetyl-S-2-hydroxyethyl-L-cysteine from tetra-
deutero-1,2-dibromoethane. Relative importance ofoxidation and
glutathione conjugation in vivo. Biochem. Pharmacol. 30: 2499-
2502 (1981).